Abstract
This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.
Lingua originale | English |
---|---|
pagine (da-a) | 10-23 |
Numero di pagine | 14 |
Rivista | Digestive and Liver Disease |
Volume | 51 |
Stato di pubblicazione | Published - 2019 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2721???
- ???subjectarea.asjc.2700.2715???